Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice
Journal of Aesthetic Medicine · 2025
DOI: 10.3390/jaestheticmed1020006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aesthetic Medicine, 2025. Verfasst von César Daniel Villarreal-Villarreal und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Androgenetic alopecia (AGA) is the most prevalent form of hair loss in humans. Oral minoxidil and dutasteride are widely used treatments, while intradermal dutasteride mesotherapy has recently gained interest as a complementary approach. However, comparative studies in real-world settings are lacking.
Objective
The aim was to compare the effectiveness and safety of four AGA therapies: oral minoxidil alone (OM), OM plus oral dutasteride (OM + OD), OM plus mesotherapy (OM + MD), and a combination of all three (CT).
Methods
A retrospective study was conducted, including 280 adult patients (mean age 35 ± 9.4 years) with AGA, excluding those with recent treatment (last 3 months) or other hair loss disorders. The therapeutic response was assessed by comparing treatment outcomes from standardized clinical images at 6 and 12 months using a four-point improvement scale. Patient satisfaction was also assessed using a four-point subjective scale.
Results
Participants were divided into four treatment groups. In total, 74 patients (26.4%) were treated with OM, 65 patients (23.2%) with OM + OD, 61 patients (21.8%) with OM + MD, and 80 patients (28.6%) with CT. At 12 months, group 4 treated with CT showed significantly better results in both frontal and vertex areas (p < 0.001), while group 3 (OM + MD) performed best at 6 months in the vertex. Side effects were mild and infrequent, with hypertrichosis being the most common. Erectile dysfunction was reported with a lower incidence than reported in the literature: two patients (3.1%) in group 2 (OM + OD) and three (3.8%) patients in CT. Overall, no serious adverse events were detected.
Conclusions
Combining oral minoxidil, oral dutasteride, and mesotherapy with dutasteride yields the most effective results for AGA with a favorable safety profile.
Zitieren
APA
Villarreal-Villarreal, C. D., Boland-Rodriguez, E., Gonzalez-Macias, C., Garza, J. F. M. L., Saceda-Corralo, D., & Vano-Galvan, S. (2025). Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice. Journal of Aesthetic Medicine. https://doi.org/10.3390/jaestheticmed1020006
Vancouver
Villarreal-Villarreal CD, Boland-Rodriguez E, Gonzalez-Macias C, Garza JFML, Saceda-Corralo D, Vano-Galvan S. Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice. Journal of Aesthetic Medicine. 2025. doi:10.3390/jaestheticmed1020006
BibTeX
@article{VillarrealVillarreal2025,
author = {Villarreal-Villarreal, César Daniel and Boland-Rodriguez, Estefanía and Gonzalez-Macias, Carolina and Garza, Juan Francisco Molina-de la and Saceda-Corralo, David and Vano-Galvan, Sergio},
title = {Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice},
journal = {Journal of Aesthetic Medicine},
year = {2025},
doi = {10.3390/jaestheticmed1020006}
}
EUVIMED